Graeme Sloan – Managing Director – Kali Metals (ASX:KM1) is a portfolio of assets that represents one of the largest and most prospective exploration packages across Australia’s world leading hard-rock lithium fields.
Copyright 2024 – Finance News Network
16 Sep 2024 - Quantum Brilliance CEO Mark Luo discusses how his company is pioneering quantum computing with synthetic diamonds, offering a miniaturised and energy-efficient alternative. He highlights the company's rapid growth since its spin-out from the Australian National University, its unique approach to quantum technology and the enormous commercial potential of quantum at the edge.
18 Apr 2024 - Anax Metals (ASX:ANX) CEO Geoff Laing discusses the company's innovative approach to mining as its pioneers bioleaching tech for sustainable resource extraction.
08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
03 Mar 2023 - IVE Group Limited (ASX:IGL) Executive Chairman Geoff Selig discusses the company's half-year financial results, commenting on key drivers, the Lasoo platform launch, the Ovato acquisition and the company's partnership with Iberdrola.
30 Aug 2023 - icetana Limited (ASX:ICE) Non-Executive Chair Matt Macfarlane discusses his transition from the CEO role, the company's artificial intelligence solution, annual recurring revenue growth, and the recent contract secured with the Sydney Opera House.
16 Sep 2019 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO, Brent Barnes, talks FY19 results and outlook, including adoption of the company's culture plate reading device APAS Independence, the sales process and regulatory approval.
16 Dec 2019 - Sienna Cancer Diagnostics Limited (ASX:SDX) Managing Director and CEO Carl Stubbings talks about the company's capital raising and co-development of tests using its SIEN-NET liquid biopsies platform technology.
17 Dec 2019 - Integrated Payment Technologies (ASX:IP1) CEO, Dean Martin discusses its payments solutions ClickSuper and PayVu, industry tailwinds, new features and platform integration.
13 Mar 2020 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO, Dr Michael Baker talks 1H20 results progress with the company's lead product Zolpimist, the spay version of Sanofi’s blockbuster insomnia drug Ambien and focus for 2020.